Yongxian Hu, MD^1*, Yanlei Zhang^2*, Houli Zhao, MD^1*, Yiyun Wang^3*, Arnon Nagler, MD⁴, Alex Hong Chang^2* and He Huang, MD, PhD¹

¹Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
²Shanghai YaKe Biotechnology Ltd, Shanghai, China
³Bone Marrow Transplantation Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
⁴Chaim sheba medical center, Tel aviv university, Tel Aviv, Israel

Paolo F Caimi^1*, Weiyun Z. Ai², Juan Pablo Alderuccio, MD³, Kirit M. Ardeshna⁴, Mehdi Hamadani, MD⁵, Brian T. Hess, MD⁶, Brad S. Kahl, MD⁷, John A. Radford, MD, FMedSci^8*, Melhem Solh, MD⁹, Anastasios Stathis, MD^10*, Pier Luigi Zinzani, MD¹¹, Jay Feingold^12*, David Ungar¹³, Yajuan Qin^13*, Shui He^13* and Carmelo Carlo-Stella, MD¹⁴

¹University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH
²Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, CA
³Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
⁴Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁵Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
⁶Division of Hematology and Medical Oncology, Department of Medicine, Medical University of South Carolina, Charleston, SC
⁷Department of Medicine, Oncology Division, Washington University, St. Louis, MO
⁸The University of Manchester and The Christie NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom
⁹Blood and Marrow Transplant Program at Northside Hospital, Atlanta, GA
¹⁰Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
¹¹Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
¹²ADC Therapeutics America, Inc, Murray Hill, NJ
¹³Clinical Development, ADC Therapeutics America, Inc, Murray Hill, NJ
¹⁴Department of Oncology and Hematology, Humanitas Clinical and Research Center - IRCCS, Humanitas University, Rozzano, Italy

Tycel J. Phillips, MD¹, Adam J Olszewski, MD², Javier Munoz, MD³, Tae Min Kim, MD, PhD^4*, Dok Hyun Yoon^5*, Richard Greil, MD⁶, Jason Westin, MD⁷, Ulrich Jaeger, MD⁸, Miguel Canales^9*, Cindy Chen^10*, Betsy Althaus¹⁰, Carol O’Hear^10*, Raluca Negricea^10*, Yuying Xie^10*, Ronald McCord^10*, Enkhtsetseg Purev¹⁰ and Anusha Vallurupalli^11*

¹University of Michigan, Ann Arbor, MI
²Lifespan Cancer Institute, Warren Alpert Medical School of Brown University, Providence, RI
³Banner MD Anderson Cancer Center, Gilbert, AZ
⁴Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
⁵Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁶Paracelsus Medical University, Salzburg, Austria
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Medical University of Vienna, Vienna, Austria
⁹Hospital Universitario La Paz, Madrid, Spain
¹⁰Genentech, Inc., South San Francisco, CA
¹¹University of Kansas Cancer Center, Kansas City, KS

Andrew Davies^1,2*, Josh Caddy^3*, Katy Mercer^3*, Geoff N Saunders^3*, Louise Stanton^3*, Graham P. Collins, MD, DPhil⁴, Thomas E C Cummin, MRCP MBBCh BSc^1*, Anna Schuh, MD⁵, Kirit M. Ardeshna⁶, Andrew McMillan⁷, John A. Radford, MD, FMedSci^8*, David John Lewis, MD^9*, Adam Coleman^2*, Gareth Griffiths^3*, Cathy Burton, MBBChir, MA, MD, FRCPath^10*, Sharon Barrans^10* and Peter Johnson, MD, FRCP¹

¹Cancer Research UK, Cancer Services, University of Southampton, Southampton, United Kingdom
²CRUK Experimental Cancer Medicines Centre, University of Southampton, Southampton, United Kingdom
³CRUK Southampton Clinical Trials Unit, University of Southampton, Southampton, United Kingdom
⁴Department of Clinical Haematology, Oxford University Hospitals, Oxford, United Kingdom
⁵Molecular Diagnostic Centre, Department of Oncology, University of Oxford, Oxford, United Kingdom
⁶Department of Haematology, University College Hospitals London, London, United Kingdom
⁷Center for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
⁸The Christie NHS Foundation Trust, Manchester, United Kingdom
⁹Department of Haematology, Derriford Hospital, Plymouth, United Kingdom
¹⁰Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds, United Kingdom

Jun Zhu, MD¹, Zhitao Ying, MD^1*, Yuqin Song, MD, PhD^1*, Haiyan Yang, MD, PhD^2*, Ye Guo, MD^3*, Wenyu Li, PhD⁴, Dehui Zou, MD^5*, Daobin Zhou, MD, PhD^6*, Zhao Wang, MD⁷, Mingzhi Zhang, MD^8*, Jianqiu Wu, MD^9*, Hui Liu, MD^10*, Pian Zhang^11*, Su Yang^11*, Zisong Zhou^11* and Hongxia Zheng, MD, PhD^11*

¹Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
²Department of Lymphoma, Cancer Hospital of the University of Chinese Academy of Sciences, Hangzhou, China
³Department of Medical Oncology, Shanghai East Hospital, Shanghai, China
⁴Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
⁵Lymphoma Center, Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Institute of Hematology and Blood Diseases Hospital (IH), Tianjin, China
⁶Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China
⁷Department of Hematology, Beijing Friendship Hospital, Capital Medical University, Beijing, China
⁸Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
⁹Department of Oncology, Jiangsu Institute of Cancer Research, Jiangsu Red Cross Cancer Center, Jiangsu Cancer Hospital, The Affiliated Hospital of Nanjing Medical University, Nanjing, China
¹⁰Department of Hematology, Beijing Hospital, Beijing, China
¹¹JW Therapeutics (Shanghai) Co. Ltd, Shanghai, China

Caron Jacobson, MD, MMSc¹, Frederick L. Locke, MD², Armin Ghobadi, MD³, David B. Miklos, MD, PhD⁴, Lazaros J. Lekakis, MD^5*, Olalekan O. Oluwole, MBBS, MPH⁶, Yi Lin, MD, PhD⁷, Ira Braunschweig, MD^8*, Brian T. Hill, MD⁹, John M. Timmerman, MD¹⁰, Abhinav Deol, MD¹¹, Patrick M. Reagan, MD¹², Patrick J. Stiff, MD¹³, Ian W. Flinn, MD, PhD¹⁴, Umar Farooq, MD¹⁵, Andre H. Goy, MD¹⁶, Peter A. McSweeney, MD^17*, Javier Munoz, MD¹⁸, Tanya Siddiqi, MD¹⁹, John M. Rossi, MS^20*, Adrian Bot, MD, PhD^20*, Lianqing Zheng, PhD^20*, Remus Vezan, MD, PhD²⁰, Zahid Bashir, MBBS^20*, Jenny J. Kim, MD, MS^20*, Rong Chu, PhD^20* and Sattva S. Neelapu, MD²¹

¹Dana Faber Cancer Institute, Harvard Medical School, Boston, MA
²Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
³Washington University School of Medicine, St Louis, MO
⁴Stanford University School of Medicine, Stanford, CA
⁵Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL
⁶Vanderbilt-Ingram Cancer Center, Nashville, TN
⁷Division of Hematology, Mayo Clinic, Rochester, MN
⁸Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
⁹Cleveland Clinic Foundation, Cleveland, OH
¹⁰UCLA David Geffen School of Medicine, Los Angeles, CA
¹¹Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI
¹²University of Rochester School of Medicine, Rochester, NY
¹³Loyola University Chicago Stritch School of Medicine, Maywood, IL
¹⁴Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN
¹⁵University of Iowa, Iowa City, IA
¹⁶John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹⁷Colorado Blood Cancer Institute at Presbyterian/St. Luke's Medical Center, Denver, CO
¹⁸Banner MD Anderson Cancer Center, Gilbert, AZ
¹⁹City of Hope National Medical Center, Duarte, CA
²⁰Kite, a Gilead Company, Santa Monica, CA
²¹The University of Texas MD Anderson Cancer Center, Houston, TX

Pier Luigi Zinzani, MD¹, Vladimir Melnichenko^2*, Krimo Bouabdallah, MD^3*, Jan Walewski, MD, PhD⁴, Alejandro Majlis, MD⁵, Laura Fogliatto, MD, PhD⁶, Dolores Caballero, MD, PhD⁷, Beth A. Christian, MD⁸, Zafer Gulbas, MD^9*, Muhit Özcan, MD^10*, Gilles Salles, MD, PhD¹¹, Margaret A. Shipp, MD¹², Seth Thompson^13*, Robert J Orlowski, MD^13*, Patricia Marinello^13* and Philippe Armand, MD, PhD¹⁴

¹Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
²Pirogov National Medical Surgical Center, Moscow, Russian Federation
³Hôpital Haut-Levêque, Pessac, France
⁴Maria Sklodowska-Curie Institute and Oncology Centre, Warsaw, Poland
⁵Clinica Alemana de Santiago-Chile, Santiago, Chile
⁶Serviço de Hematologia, Hospital De Clinicas, Porto Alegre RS, Brazil
⁷Hospital Clínico de Salamanca, Salamanca, Spain
⁸Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
⁹Anadolu Medical Center, Kocaeli, Turkey
¹⁰Ankara University Medical School, Ankara, Turkey
¹¹Hospices Civils de Lyon, Université Claude Bernard, Lyon, France
¹²Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
¹³Merck & Co., Inc., Kenilworth, NJ
¹⁴Dana-Farber Cancer Institute, Boston, MA

Ajay Major, MD, MBA¹, Justin Kline, MD¹, Theodore G. Karrison, PhD^2*, Paul A S Fishkin, MD³, Amy S Kimball, MD, PhD^4,5, Adam M Petrich, MD^6,7, Sreenivasa Nattam, MD⁸, Bethany G Sleckman, MD^9*, Kenneth Cohen, MD¹, Koen van Besien, MD, PhD¹⁰, Aaron P. Rapoport, MD¹¹ and Sonali M. Smith, MD¹²

¹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
²Department of Public Health Sciences, University of Chicago, Chicago, IL
³Illinois Cancer Care, Peoria, IL
⁴Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, MD
⁵Amgen, Inc., Thousand Oaks, CA
⁶Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
⁷Daiichi-Sankyo, Inc., Basking Ridge, NJ
⁸Fort Wayne Oncology Hematology, Fort Wayne, IN
⁹David C. Pratt Cancer Center, Mercy Clinic Oncology and Hematology, St. Louis, MO
¹⁰Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY
¹¹Division of Hematology and Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD
¹²Department of Oncology, University of Chicago, Chicago, IL

Carlos Galvez, MD¹, Reem Karmali, MD, MSc², Mehdi Hamadani, MD³, Leo I. Gordon, MD², Jane N. Winter, MD⁴, Shuo Ma, MD, PhD², Valerie Nelson, MD, MBA^2*, Brett Alan Palmer, BS^2*, Timothy S. Fenske, MD³, Nirav N. Shah, MD⁵, Deepa Jagadeesh, MD, MPH⁶, Andreas Klein, MD⁷, Irene Helenowski, PhD^8*, Borko Jovanovic, PhD^8*, Adam M Petrich, MD^2,9, Andrew M. Evens, DO, MMSc¹⁰ and Barbara Pro, MD²

¹Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL
²Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
³Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
⁴Division of Hematology and Oncology, Northwestern University, Chicago, IL
⁵Medical College of Wisconsin, Brookfield, WI
⁶Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Solon, OH
⁷Division of Hematology and Oncology, Tufts Medical Center, Boston, MA
⁸Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
⁹Daiichi-Sankyo, Inc., Basking Ridge, NJ
¹⁰Rutgers Cancer Institute of New Jersey, Warren, NJ

Krish Patel, MD¹, Radhakrishnan Ramchandren, MD², Michael Maris, MD^3,4, Alexander M. Lesokhin, MD⁵, Gottfried R. von Keudell, MD, PhD⁶, Bruce D. Cheson, MD⁷, Jeff Zonder, MD⁸, Erlene K. Seymour, MD⁸, Tina Catalano, MSc^9*, Gloria H. Y. Lin, PhD^9*, Bob Uger, PhD^9*, Penka S. Petrova, PhD^9*, Kathleen Roberge, ANP, MSc^9*, Yaping Shou, MD, PhD⁹ and Swami P. Iyer, MD¹⁰

¹Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
²The University of Tennessee, Knoxville, TN
³Colorado Blood Cancer Institute, Denver, CO
⁴Sarah Cannon Research Institute, Denver, CO
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC
⁸Karmanos Cancer Institute/Wayne State University, Detroit, MI
⁹Trillium Therapeutics Inc., Mississauga, ON, Canada
¹⁰The University of Texas MD Anderson Cancer Center, Houston, TX

Sanjal H Desai, MD¹, Betsy Laplant, MS^2*, William R. Macon, MD^3*, Rebecca L. King, MD³, Yucai Wang, MD, PhD¹, David J. Inwards, MD¹, Ivana Micallef, MD¹, Patrick B. Johnston, MD/ PhD⁴, Luis F. Porrata, MD¹, Stephen M. Ansell, MD, PhD⁵, Thomas M. Habermann, MD¹, Thomas E. Witzig, MD¹ and Grzegorz S. Nowakowski, MD¹

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Biomedical Statistics & Informatics, Mayo Clinic, Rochester, MN
³Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁴Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁵Mayo Clinic, Rochester, MN

Christian Grommes, MD¹, Anna Piotrowski, MD^2*, Elena Pentsova, MD^2*, Craig Nolan, MD^2*, Jasmine Francis^2*, Lisa DeAngelis, MD^3*, Lauren Schaff, MD^4* and Ingo K Mellinghoff, MD^5*

¹Neurology, Memorial Sloan Kettering Cancer, New York, NY
²Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY
⁴Neurology, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Memorial Sloan-Kettering Cancer Center, New York, NY

Ulrich Jaeger, MD¹, Michael R. Bishop, MD², Gilles Salles, MD, PhD³, Stephen J. Schuster, MD^4,5, Richard T. Maziarz, MD^6,7, Xia Han, MS^8*, Alexander Savchenko, MD^9*, Nathan Roscoe, Mbt^10*, Elena Orlando, PhD^11*, Dawson Knoblock, PhD^8*, Ranjan Tiwari, MSc^12*, Lida Bubuteishvili Pacaud, MD^8* and Paolo Corradini¹³

¹Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, AA, Austria
²Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
³Hematology Department, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre Bénite, France
⁴Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
⁵Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁶Knight Cancer Institute, Oregon Health and Science University, Portland, OR
⁷Department of Hematology, Oregon Health and Science University, Portland, OR
⁸Novartis Pharmaceuticals Corporation, East Hanover, NJ
⁹Oncology Precision Medicine, Novartis Pharmaceuticals Corporation, Cambridge, MA
¹⁰Navigate BioPharma, Carlsbad, CA
¹¹Novartis Institutes for Biomedical Research, Cambridge, MA
¹²Novartis Healthcare Pvt. Ltd, Hyderabad, India
¹³Fondazione IRCCS Instituto Nazionale dei Tumori, University of Milan, Milan, Italy

Amy S. Ruppert, PhD¹, Levi D. Pederson, MS^2*, Michael V. Knopp, MD, PhD^3*, David Poon, BS^4*, Jun Zhang, PhD^4*, Brad S. Kahl, MD⁵, Jonathan W. Friedberg, MD, MSSc⁶, Lawrence H. Schwartz, MD^7*, Wyndham H. Wilson, MD, PhD⁸, John P. Leonard, MD⁹, Nancy L. Bartlett, MD^10* and Heiko Schöder, MD^11*

¹Department of Medicine, The Ohio State University, Gahanna, OH
²Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN
³Wright Center of Innovation in Biomedical Imaging, Department of Radiology, The Ohio State University Wexner Medical Center, Columbus, OH
⁴The Ohio State University, Columbus, OH
⁵Washington University School of Medicine, Saint Louis, MO
⁶University of Rochester Medical Center, Rochester, NY
⁷Columbia University Medical Center, New York, NY
⁸Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁹Department of Medicine, Weill Cornell Medicine, New York, NY
¹⁰Department of Medicine, Washington University School of Medicine, St. Louis, MO
¹¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

John E. Godwin, MD¹, Cesar O. Freytes, MD², Michael Maris, MD^3,4, Don A. Stevens, MD⁵, Daanish Hoda, MD⁶, Bassam Mattar, MD^7*, Juan C. Varela, MD, PhD⁸, Mohamad Cherry, MD, MS⁹, James Essell, MD¹⁰, Jay Courtright, MD^11*, Suzanne R. Fanning, DO¹², Habte A. Yimer, MD¹³, Nikolaus S. Trede, MD, PhD^14*, Marina Youssef, PharmD^15*, James Lymp, PhD^14* and Carlos Bachier, MD¹⁶

¹Providence Cancer Center, Earle A. Chiles Research Institute, Portland, OR
²Texas Transplant Institute, San Antonio, TX
³Colorado Blood Cancer Institute, Denver, CO
⁴Sarah Cannon Research Institute, Nashville, TN
⁵Norton Health Care, Louisville, KY
⁶Intermountain Healthcare, Loveland Clinic for Blood Cancer Therapy, Salt Lake City, UT
⁷Cancer Center of Kansas, Wichita, KS
⁸Advent Health Blood and Marrow Transplant Program, Orlando, FL
⁹Atlantic Health System, Carol Simon Cancer Center, Morristown, NJ
¹⁰Oncology Hematology Care, Cincinnati, OH
¹¹Texas Oncology, Medical City Dallas, Dallas, TX
¹²Prisma Health, Greenville, SC
¹³Texas Oncology-Tyler, Tyler, TX
¹⁴Juno Therapeutics, a Bristol-Myers Squibb Company, Seattle, WA
¹⁵Bristol-Myers Squibb Company, Princeton, NJ
¹⁶Sarah Cannon Center for Blood Cancer at Tristar Centennial Medical Center, Nashville, TN

Qingqing Cai, PhD^1*, Hui Zhou, MD, PhD^2*, Zhiming Li, MD, PhD^1*, Wenyu Li, PhD³, Yudan Wu, MD, PhD^4*, Bingyi Wu, MD, PhD⁵, Hui Yang, MD, PhD^5*, Stephen Yang Liang, MD, PhD⁶, Ning Su, MM^1*, Panpan Liu, MD, PhD^1*, Xuanye Zhang, MD, PhD^1*, Yi Xia, MD, PhD^1* and Shuyun Ma, MM^1*

¹Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
²Department of Lymphoma and Hematology, Hunan Cancer Hospital, Changsha, China
³Division of lymphoma, Department of Clinical Oncology, Guangdong General Hospital, Guangzhou, China
⁴Department of Hematology, Sun Yat-sen Memorial Hospital,, Guangzhou, China
⁵Department of Hematology, Shunde Hospital of Southern Medical University, Foshan, China
⁶Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China

Nassim Djebli^1*, Peter N Morcos^2*, Félix Jaminion^1*, Elena Guerini^1*, Nicole A Kratochwil^1*, Nicole Justies^1*, Eginhard Schick^1*, Antonia Kwan³, Kathryn Humphrey^4*, Linda Lundberg^5* and David Carlile^6*

¹Roche Innovation Center Basel, Roche Pharma Research and Early Development, Basel, Switzerland
²Roche Innovation Center New York, Roche Pharma Research and Early Development, New York, NY
³Genentech, Inc., South San Francisco, CA
⁴Roche Products Ltd, Welwyn Garden City, United Kingdom
⁵F. Hoffmann-La Roche Ltd, Basel, Switzerland
⁶Roche Innovation Center Welwyn, Roche Pharma Research and Early Development, Welwyn Garden City, United Kingdom

Jingjing Ma, Dr^1*, Bobin Chen, MD, PhD¹, Lin Zhiguang, Dr^1*, Qing Li, Dr^2*, Hui Kang, Dr^1* and Yan Ma, Dr^1*

¹Department of Hematology, Huashan Hospital, Fudan University, Shanghai, China
²Department of hematology, Huashan Hospital, Fudan University, Shanghai, China

Julio C. Chavez, MD¹, Frederick L. Locke, MD², Ellen Napier, CRNP^3,4*, Carl Simon, MS^5*, Andrew Lewandowski, PhD^5*, Rakesh Awasthi, PhD^6*, Boris Engels, PhD^5*, Petrina Georgala, PhD^7*, Attilio Bondanza, MD⁸ and Stephen J. Schuster, MD³

¹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
³Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁴Clinical Research Unit, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁵Novartis Institutes for BioMedical Research, Cambridge, MA
⁶Novartis Institutes for BioMedical Research, East Hanover, NJ
⁷Novartis Pharmaceuticals Corporation, East Hanover, NJ
⁸Novartis Institutes for BioMedical Research, Basel, Switzerland

Michael W. Schuster, MD¹, Miguel A Canales, MD, PhD^2,3, Jason Westin, MD⁴, Josée M Zijlstra, MD, PhD^5*, George A Follows, MD, PhD^6*, Reem Karmali, MD, MSc⁷, Nagesh Kalakonda, MD^8*, Andre H. Goy, MD⁹, Rene-Olivier Casasnovas, MD^10*, Joost Vermaat, MD, PhD¹¹, Eric Van Den Neste, MD^12*, Sylvain Choquet, MD^13*, Catherine Thieblemont, MD, PhD¹⁴, Federica Cavallo, MD, PhD^15*, Maria de Fatima De La Cruz, MD^16*, Brian T. Hill, MD¹⁷, Herve Tilly, MD, PhD¹⁸, Shireen Kassam, MBBS, FRCPath, PhD^19*, Reda Bouabdallah, MD^20*, Ulrich Jaeger, MD²¹, Ronit Gurion, MD^22*, Paolo Caimi, MD²³, Peter Martin, FRCPC, MD, MS²⁴, Andrew Davies, MD, PhD^25*, Sonali M. Smith, MD²⁶, Graham P. Collins, MD, DPhil²⁷, Fritz Offner, MD, PhD²⁸, Gilles Salles, MD, PhD²⁹, Xiwen Ma^30*, Kelly Corona^30*, Jean-Richard Saint-Martin^30*, Anita A. Joshi^31*, Kamal Chamoun, MD^30*, Hongwei Wang, MD, PhD^31*, Jatin J. Shah, MD^30*, Sharon Shacham, PhD, MBA^30*, Michael G Kauffman, MD, PhD³⁰ and Marie Maerevoet, MD^32*

¹Stony Brook University, Stony Brook, NY
²La Paz University Hospital, Madrid, Spain
³Hematology and Hemotherapy Unit, La Paz University Hospital-IdiPAZ, Madrid, Spain
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands
⁶Addenbrooke’s Hospital, Cambridge, United Kingdom
⁷Division of Hematology Oncology, Northwestern University, Chicago, IL
⁸University of Liverpool, Liverpool, United Kingdom
⁹Division of Lymphoma, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹⁰Hématologie Clinique and INSERM 1231, CHU Dijon, Dijon, France
¹¹Department of Hematology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands
¹²Cliniques universitaires Saint-Luc, Brussels, BEL
¹³Hospital Pitie Salpetriere, Paris, France
¹⁴APHP, Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris Diderot, Paris, France
¹⁵Department of Molecular Biotechnologies and Health Sciences, Division of Hematology, University of Torino, Torino, Italy
¹⁶Hospital Universitario Virgen del Rocio, Sevilla, Spain
¹⁷Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH
¹⁸Centre Henri Becquerel, Rouen, France
¹⁹King's College Hospital, London, United Kingdom
²⁰Institut Paoli-Calmettes, Marseille, France
²¹Clinical Division of Hematology and Hemostaseology, Department of Medicine I, Medical University of Vienna, Vienna, AA, Austria
²²Rabin Medical Center, Petah Tikva, Israel
²³University Hospitals Cleveland Medical Center, Cleveland, OH
²⁴Weill Cornell Medicine-New York Presbyterian Hospital, New York, NY
²⁵Cancer Research UK Centre/Experimental Cancer Medicines Centre, University of Southampton, Southampton, United Kingdom
²⁶Department of Oncology, University of Chicago, Chicago, IL
²⁷Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
²⁸University Hospital Ghent, Gent, Belgium
²⁹Centre Hospitalier Lyon-Sud, Lyon, France
³⁰Karyopharm Therapeutics, Newton, MA
³¹Karyopharm Therapeutics Inc., Newton, MA
³²Institut Jules Bordet, Brussels, Belgium